The route to financial sustainability of a large Public Private Partnership—the example of the clinical trial network conect4children (c4c)
Laetitia Paumard, Heidrun Hildebrand, Marianne Engel, Pirkko Lepola, Esther Montero, Frank Tennigkeit, Magda Rosenmöller

TL;DR
This paper explores how the conect4children PPP achieved financial sustainability by creating a standalone entity to offer market-tested services.
Contribution
It presents a novel strategy for financial sustainability in large PPPs through the parallel setup of a standalone organization.
Findings
A dedicated work package on financial sustainability was implemented from the project's start.
A standalone entity, c4c-Stichting, was established to translate research into market-tested services.
The approach offers insights for planning financial sustainability in large-scale initiatives.
Abstract
The financial sustainability of publicly funded initiatives, particularly Public Private Partnerships (PPPs), is crucial for ensuring the intended long-term impact beyond the project’s funding phase. Despite many initiatives aspiring to lasting impact, very few practical examples and little evidence are available on successful financial sustainability strategies, and even fewer are available on the path to achieve the financial autonomy of any successor organisation. This paper intends to shed light on this aspect by exploring the strategy and challenges towards the financial sustainability of conect4children (c4c), an Innovative Medicines Initiative (IMI)-funded PPP establishing a pan-European paediatric clinical trial network to facilitate and support the planning and conduct of paediatric clinical trials. The c4c project was planned for a lasting impact from the start. An entire…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealth Systems, Economic Evaluations, Quality of Life · Pharmaceutical studies and practices · Pharmaceutical Economics and Policy
